Nalaganje...

Association between cancer prevalence and use of thiazolidinediones: results from the Vermont Diabetes Information System

BACKGROUND: Peroxisome proliferator-activated receptors (PPARs) have emerged as important drug targets for diabetes. Drugs that activate PPARγ, such as the thiazolidinediones (TZDs), are widely used for treatment of Type 2 diabetes mellitus. PPARγ signaling could also play an anti-neoplastic role in...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Ramos-Nino, Maria E, MacLean, Charles D, Littenberg, Benjamin
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2007
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC1934377/
https://ncbi.nlm.nih.gov/pubmed/17584937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1741-7015-5-17
Oznake: Označite
Brez oznak, prvi označite!